New Jersey Nursing Homes Reducing Reliance on Anti-Psychotic Drugs

All over the United States, nursing homes are treating dementia residents with anti-psychotic medication despite an FDA warning that use of these drugs increases risk of death in people with dementia. These drugs are being misused as an “easy way out” to deal with challenging patients. In light of this, New Jersey nursing homes have actively taken measures to reduce their use of these drugs. Many of the state’s nursing homes have implemented effective strategies tailored to meet the specific needs of individual dementia residents. As reported this past week in the Star Ledger, New Jersey nursing homes currently together rank fourth-lowest in the country for use of anti-psychotic medication.

Over the past 10 years Sugarman Law has represented several people who received the wrong medications or the wrong dosage of medications in nursing homes and other elder care facilities. Medication errors like these can be deadly and catastrophic. It’s nice to see that New Jersey nursing homes are improving their care related to anti-psychotic medications.


To read more about this topic, click here.

Disclaimer: No aspect of this advertisement has been approved by the Supreme Court. Years listed and methodology for inclusion.

Winning Results

  • $1,400,000

    against a nursing home for the choking death of a resident

  • $1,000,000

    against an assisted living facility for injury and wrongful death of a resident

  • $930,000

    against a Middlesex County nursing home for a resident’s pressure ulcers and wrongful death

  • $3,000,000

    settlement for workers with mesothelioma, lung cancer, and asbestosis caused by asbestos in the workplace